Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (TSX:MSCL)

No current opinion is available.

Bullboard Posts (TSX:MSCL)

Satellos Reports Q3 2024 Financial Results and Provides Clin

Breaking News: $MSCLF Satellos Reports Q3 2024 Financial Results and Provides Clinical Update- Completed enrollment for SAT-3247 in...
whytestocks - 10 days ago

RE:RE:Webinar Recap: $MSCL CEO Frank Gleeson and CFO Liz Williams

Rug pull on horizon. Up on no volume. Bad look.
BaddPitt - November 5, 2024

RE:Webinar Recap: $MSCL CEO Frank Gleeson and CFO Liz Williams

Satellos to Participate in November 2024 Investor Conferences
G1945V - November 4, 2024

Webinar Recap: $MSCL CEO Frank Gleeson and CFO Liz Williams

<< View Post To Watch Video >>
bmreed - October 7, 2024

Webinar $MSCL CEO Frank Gleeson Oct 3 @ 1PM ET / 10AM PT

Live Webinar - Satellos Bioscience (MSCL) CEO Frank Gleeson and CFO Elizabeth Williams Thursday, October 3rd at 1PM ET / 10AM PT Q...
bmreed - September 28, 2024

Filing to Commence a Phase 1 Clinical Trial

Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247  
G1945V - July 11, 2024